• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在活动性类风湿关节炎晚期患者中使用非甾体类抗炎药。

USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ADVANCED ACTIVE RHEUMATOID ARTHRITIS.

机构信息

Dubrava University Hospital, Department of Physical and Rehabilitation Medicine with Rheumatology, Zagreb, Croatia.

Josip Juraj Strossmayer University of Osijek, School of Medicine, Osijek, Croatia.

出版信息

Acta Clin Croat. 2022 Dec;61(4):588-598. doi: 10.20471/acc.2022.61.04.04.

DOI:10.20471/acc.2022.61.04.04
PMID:37868178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10588376/
Abstract

This study aimed to determine whether patients with active rheumatoid arthritis (RA) regularly take non-steroidal anti-inflammatory drugs (NSAIDs) and to clarify whether their decision to take NSAIDs depends on disease activity, intensity of pain, or functional status. The study also aimed to identify the risk factors for gastrointestinal side effects. Over 6 months, we conducted a cross-sectional single-center study of consecutively hospitalized patients with confirmed RA. Activities of daily living, pain intensity, and disease activity were evaluated by the Health Assessment Questionnaire, visual analog scale, and disease activity score, respectively, in 28 joints. Of 73 patients diagnosed with RA, 48 (66%) regularly took NSAIDs. Compared to non-users, NSAID users used glucocorticoids less frequently. The decision to use NSAIDs was independent of disease activity, pain intensity, degree of functional impairment, or presence of gastrointestinal risk factors. However, a higher degree of functional impairment was associated with a longer duration of continuous NSAID and glucocorticoid use. NSAIDs are still relevant for RA treatment. The decision to use them is not necessarily affected by disease activity or pain intensity, but their prolonged use is required in patients with a higher degree of functional disability. NSAIDs enable exclusion of glucocorticoid use, sparing patients of glucocorticoid-related side effects.

摘要

本研究旨在确定活动性类风湿关节炎(RA)患者是否定期服用非甾体抗炎药(NSAIDs),并阐明他们服用 NSAIDs 的决定是否取决于疾病活动度、疼痛强度或功能状态。本研究还旨在确定胃肠道副作用的风险因素。在 6 个月的时间里,我们对连续住院的确诊 RA 患者进行了一项横断面单中心研究。通过健康评估问卷、视觉模拟量表和 28 个关节的疾病活动评分,分别评估日常生活活动、疼痛强度和疾病活动度。在 73 名确诊为 RA 的患者中,有 48 名(66%)定期服用 NSAIDs。与非使用者相比,NSAID 使用者较少使用糖皮质激素。使用 NSAIDs 的决定与疾病活动度、疼痛强度、功能障碍程度或胃肠道风险因素无关。然而,较高的功能障碍程度与持续 NSAID 和糖皮质激素使用时间的延长有关。NSAIDs 仍然是 RA 治疗的重要药物。使用 NSAIDs 的决定不一定受疾病活动度或疼痛强度的影响,但在功能障碍程度较高的患者中需要长期使用 NSAIDs。NSAIDs 可以排除糖皮质激素的使用,使患者免受糖皮质激素相关副作用的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/e8ab8077606f/acc-61-588-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/93c460f86e8b/acc-61-588-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/c256d0bd6907/acc-61-588-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/8c9d2e222bab/acc-61-588-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/e23276b3931e/acc-61-588-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/3bb736a5421a/acc-61-588-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/e8ab8077606f/acc-61-588-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/93c460f86e8b/acc-61-588-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/c256d0bd6907/acc-61-588-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/8c9d2e222bab/acc-61-588-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/e23276b3931e/acc-61-588-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/3bb736a5421a/acc-61-588-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b8/10588376/e8ab8077606f/acc-61-588-f6.jpg

相似文献

1
USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ADVANCED ACTIVE RHEUMATOID ARTHRITIS.在活动性类风湿关节炎晚期患者中使用非甾体类抗炎药。
Acta Clin Croat. 2022 Dec;61(4):588-598. doi: 10.20471/acc.2022.61.04.04.
2
Chronological effects of non-steroidal anti-inflammatory drug therapy on oxidative stress and antioxidant status in patients with rheumatoid arthritis.非甾体抗炎药治疗对类风湿关节炎患者氧化应激和抗氧化状态的时间效应。
Clin Rheumatol. 2021 May;40(5):1767-1778. doi: 10.1007/s10067-020-05438-0. Epub 2020 Oct 3.
3
Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.用于儿童和青少年慢性非癌性疼痛的非甾体抗炎药(NSAIDs)
Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD012537. doi: 10.1002/14651858.CD012537.pub2.
4
Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?非甾体抗炎药对心血管风险的影响:在骨关节炎和类风湿关节炎中是否相同?
Mod Rheumatol. 2017 Jul;27(4):559-569. doi: 10.1080/14397595.2016.1232332. Epub 2016 Sep 23.
5
The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.类风湿关节炎患者中糖皮质激素的临床效果可能会因其他疗法使用减少而被掩盖。
Arthritis Rheum. 2004 Apr 15;51(2):233-8. doi: 10.1002/art.20251.
6
Non-steroidal anti-inflammatory drugs (NSAIDs) for trigger finger.非甾体抗炎药(NSAIDs)治疗扳机指。
Cochrane Database Syst Rev. 2021 Apr 14;4(4):CD012789. doi: 10.1002/14651858.CD012789.pub2.
7
A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.针对西米德兰兹郡风湿病诊所使用COX - 2选择性非甾体抗炎药(NSAIDs)情况与英国国家卫生与临床优化研究所(NICE)指南相关的一项区域性审计。
Rheumatology (Oxford). 2005 Jul;44(7):921-4. doi: 10.1093/rheumatology/keh642. Epub 2005 Apr 12.
8
Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity.缓解期或低疾病活动度的类风湿关节炎患者成功停用非甾体抗炎药的关键因素。
Clin Rheumatol. 2018 Feb;37(2):307-314. doi: 10.1007/s10067-017-3863-7. Epub 2017 Oct 8.
9
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.环氧化酶-2选择性非甾体抗炎药(依托度酸、美洛昔康、塞来昔布、罗非昔布、艾瑞昔布、伐地昔布和鲁米昔布)用于骨关节炎和类风湿性关节炎:系统评价与经济学评估
Health Technol Assess. 2008 Apr;12(11):1-278, iii. doi: 10.3310/hta12110.
10
A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.韩国关节炎患者抗关节炎药物的横断面回顾性评估。
Curr Med Res Opin. 2003;19(7):597-602. doi: 10.1185/030079903125002252.

引用本文的文献

1
Interplay of rheumatoid arthritis and cardiovascular disease: Insights and prospects.类风湿性关节炎与心血管疾病的相互作用:见解与展望。
SAGE Open Med. 2025 Jul 23;13:20503121251330171. doi: 10.1177/20503121251330171. eCollection 2025.
2
Antioxidant Therapies as Emerging Adjuncts in Rheumatoid Arthritis: Targeting Oxidative Stress to Enhance Treatment Outcomes.抗氧化疗法作为类风湿关节炎中新兴的辅助治疗手段:针对氧化应激以提高治疗效果。
Int J Mol Sci. 2025 Mar 21;26(7):2873. doi: 10.3390/ijms26072873.
3
Use of platelet-rich plasma in rheumatic diseases.

本文引用的文献

1
The effect of smoking on disease activity in rheumatoid arthritis - our experience.吸烟对类风湿关节炎疾病活动的影响-我们的经验。
Acta Clin Croat. 2020 Jun;59(2):312-317. doi: 10.20471/acc.2020.59.02.15.
2
Rheumatoid arthritis: previously untreated early disease.类风湿关节炎:既往未治疗的早期疾病。
BMJ Clin Evid. 2016 Aug 1;2016:1124.
3
Treatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations.分子靶向药物治疗类风湿关节炎:疗效与局限性
富血小板血浆在风湿性疾病中的应用。
Rheumatol Int. 2024 Dec 31;45(1):13. doi: 10.1007/s00296-024-05776-1.
4
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry.炎症性关节炎患者临床结局评估:来自英国医用大麻注册中心的分析
Int Clin Psychopharmacol. 2025 Jul 1;40(4):242-249. doi: 10.1097/YIC.0000000000000556. Epub 2024 Jul 2.
J Orthop Sci. 2015 Nov;20(6):951-7. doi: 10.1007/s00776-015-0766-9. Epub 2015 Sep 25.
4
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.2010年类风湿关节炎分类标准:美国风湿病学会/欧洲抗风湿病联盟合作项目
Arthritis Rheum. 2010 Sep;62(9):2569-81. doi: 10.1002/art.27584.
5
Rheumatoid arthritis.类风湿关节炎。
Lancet. 2010 Sep 25;376(9746):1094-108. doi: 10.1016/S0140-6736(10)60826-4.
6
Inadequate use of preventive strategies in patients receiving NSAIDs.在使用 NSAIDs 的患者中,预防策略的使用不足。
Clin Drug Investig. 2005;25(4):265-70. doi: 10.2165/00044011-200525040-00006.
7
NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care.非甾体抗炎药相关性消化不良和溃疡:一项初级保健中的前瞻性队列研究
Dig Dis. 2006;24(1-2):189-94. doi: 10.1159/000090321.
8
Nonsteroidal anti-inflammatory drugs.非甾体抗炎药。
Phys Med Rehabil Clin N Am. 2006 May;17(2):347-54, vi. doi: 10.1016/j.pmr.2005.12.012.
9
Gastrointestinal prophylactic therapy among patients with arthritis treated by rheumatology specialists.风湿病专科医生治疗的关节炎患者的胃肠道预防性治疗。
J Rheumatol. 2006 Apr;33(4):779-84. Epub 2006 Mar 1.
10
Underutilization of preventive strategies in patients receiving NSAIDs.非甾体抗炎药(NSAIDs)使用者预防策略的未充分利用。
Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31. doi: 10.1093/rheumatology/keg495.